Atea Pharmaceuticals, Inc. 10-Q filing
Filed 2025-08-07 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0000950170-25-105123
- Form type
- 10-Q
- CIK
- 0001593899
- Primary document
- https://www.sec.gov/Archives/edgar/data/1593899/000095017025105123/avir-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Atea Pharmaceuticals, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-80.4M | - | - |
| Net Income | $-71.4M | - | - |
| Eps Basic | -0.85 | - | - |
| Eps Diluted | -0.85 | - | - |
| Cash And Equivalents | $87.7M | - | - |
| Total Assets | $391.6M | - | - |
| Total Liabilities | $27.2M | - | - |
| Shareholders Equity | $364.4M | - | - |
| Operating Cash Flow | $-63.4M | - | - |